Schedule 13D ownership disclosure

XYNOMIC PHARMACE

Security class unavailable · CUSIP: 98421X102

Event date: 2019-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
45.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-19-009702
Form type
SC 13D
Filer
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
CIK
CIK 1697805
Filed
May 29, 2019
Reporting period
May 15, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub